South Korea signs with Pfizer for extra 40 million COVID-19 vaccine doses

0
142
FILE PHOTO: A health worker gets a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a COVID-19 vaccination center in Seoul, South Korea, March 10, 2021. REUTERS/Kim Hong-Ji/File Photo

SEOUL (Reuters) – South Korea said on Saturday it signed a contract with Pfizer Inc to purchase an additional 40 million doses of its COVID-19 vaccine amid fears of spiking infections at home.

That brings the current amount of Pfizer vaccines to 66 million doses, it said in a statement.

It added that it had secured a total 192 million doses of vaccines, including those from Moderna Inc, AstraZeneca PLC, Johnson & Johnson’s and Novavax.